Literature DB >> 15154837

Tissue-engineered skin substitutes: from in vitro constructs to in vivo applications.

François A Auger1, François Berthod, Véronique Moulin, Roxane Pouliot, Lucie Germain.   

Abstract

The field of skin tissue engineering is a paradigm for the various efforts towards the reconstruction of other tissues and organ substitutes. As skin replacement, this biotechnological approach has evolved from simple cultured autologous epidermal sheets to more complex bilayered cutaneous substitutes. The various types of such substitutes are herein presented with their intended use. However, two integrative characteristics are analysed more specifically because of their critical role: neovascularization and re-innervation. Furthermore, the in vitro use of these various skin substitutes has shed light on various physiological and pathological phenomena. Thus, not only the in vivo application of these skin substitutes as grafts, but also their in vitro value as skin models, are presented.

Mesh:

Substances:

Year:  2004        PMID: 15154837     DOI: 10.1042/BA20030229

Source DB:  PubMed          Journal:  Biotechnol Appl Biochem        ISSN: 0885-4513            Impact factor:   2.431


  28 in total

1.  Active scaffolds for on-demand drug and cell delivery.

Authors:  Xuanhe Zhao; Jaeyun Kim; Christine A Cezar; Nathaniel Huebsch; Kangwon Lee; Kamal Bouhadir; David J Mooney
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-13       Impact factor: 11.205

Review 2.  Tissue engineering of replacement skin: the crossroads of biomaterials, wound healing, embryonic development, stem cells and regeneration.

Authors:  Anthony D Metcalfe; Mark W J Ferguson
Journal:  J R Soc Interface       Date:  2007-06-22       Impact factor: 4.118

3.  Producing organs in the laboratory.

Authors:  Mark E Furth; Anthony Atala
Journal:  Curr Urol Rep       Date:  2008-11       Impact factor: 3.092

4.  Macromolecular crowding amplifies adipogenesis of human bone marrow-derived mesenchymal stem cells by enhancing the pro-adipogenic microenvironment.

Authors:  Xiu Min Ang; Michelle H C Lee; Anna Blocki; Clarice Chen; L L Sharon Ong; H Harry Asada; Allan Sheppard; Michael Raghunath
Journal:  Tissue Eng Part A       Date:  2013-12-03       Impact factor: 3.845

5.  Is tissue engineering a new paradigm in medicine? Consequences for the ethical evaluation of tissue engineering research.

Authors:  Leen Trommelmans; Joseph Selling; Kris Dierickx
Journal:  Med Health Care Philos       Date:  2009-07-24

6.  Surface topography induces 3D self-orientation of cells and extracellular matrix resulting in improved tissue function.

Authors:  Maxime D Guillemette; Bo Cui; Emmanuel Roy; Robert Gauvin; Claude J Giasson; Mandy B Esch; Patrick Carrier; Alexandre Deschambeault; Michel Dumoulin; Mehmet Toner; Lucie Germain; Teodor Veres; Francois A Auger
Journal:  Integr Biol (Camb)       Date:  2009-01-15       Impact factor: 2.192

7.  Making more matrix: enhancing the deposition of dermal-epidermal junction components in vitro and accelerating organotypic skin culture development, using macromolecular crowding.

Authors:  Paula Benny; Cedric Badowski; E Birgitte Lane; Michael Raghunath
Journal:  Tissue Eng Part A       Date:  2014-10-09       Impact factor: 3.845

Review 8.  A pathologist's perspective on induced pluripotent stem cells.

Authors:  Noriko Watanabe; Katherine E Santostefano; Anthony T Yachnis; Naohiro Terada
Journal:  Lab Invest       Date:  2017-07-31       Impact factor: 5.662

9.  Improving 2D and 3D Skin In Vitro Models Using Macromolecular Crowding.

Authors:  Paula Benny; Cedric Badowski; E Birgitte Lane; Michael Raghunath
Journal:  J Vis Exp       Date:  2016-08-22       Impact factor: 1.355

10.  Combination of stromal cell-derived factor-1 and collagen-glycosaminoglycan scaffold delays contraction and accelerates reepithelialization of dermal wounds in wild-type mice.

Authors:  Aparajita Sarkar; Soner Tatlidede; Saja Sandra Scherer; Dennis P Orgill; François Berthiaume
Journal:  Wound Repair Regen       Date:  2010-12-06       Impact factor: 3.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.